Kiyoshi Moriyama

1.8k total citations
54 papers, 1.2k citations indexed

About

Kiyoshi Moriyama is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Medicine. According to data from OpenAlex, Kiyoshi Moriyama has authored 54 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pulmonary and Respiratory Medicine, 14 papers in Surgery and 10 papers in Molecular Medicine. Recurrent topics in Kiyoshi Moriyama's work include Antibiotic Resistance in Bacteria (10 papers), Respiratory Support and Mechanisms (7 papers) and Bacterial biofilms and quorum sensing (6 papers). Kiyoshi Moriyama is often cited by papers focused on Antibiotic Resistance in Bacteria (10 papers), Respiratory Support and Mechanisms (7 papers) and Bacterial biofilms and quorum sensing (6 papers). Kiyoshi Moriyama collaborates with scholars based in Japan, United States and France. Kiyoshi Moriyama's co-authors include Teiji Sawa, Jeanine P. Wiener-Kronish, Kunihiko Kooguchi, Temitayo Ajayi, Masaru Shimizu, Mao Kinoshita, Junzo Takeda, Akitoshi Ishizaka, Hiroshi Morisaki and Leonard R. Allmond and has published in prestigious journals such as PLoS ONE, American Journal of Respiratory and Critical Care Medicine and Biochemical and Biophysical Research Communications.

In The Last Decade

Kiyoshi Moriyama

48 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kiyoshi Moriyama Japan 21 422 354 271 196 186 54 1.2k
Isao Nishi Japan 19 377 0.9× 162 0.5× 149 0.5× 278 1.4× 53 0.3× 98 1.6k
Ming-Cheng Wang Taiwan 22 269 0.6× 225 0.6× 99 0.4× 207 1.1× 51 0.3× 51 1.2k
Fotini Fligou Greece 20 504 1.2× 144 0.4× 173 0.6× 143 0.7× 59 0.3× 59 1.3k
Ming‐Han Tsai Taiwan 25 170 0.4× 318 0.9× 396 1.5× 120 0.6× 87 0.5× 104 1.9k
Yizhi Peng China 25 254 0.6× 554 1.6× 109 0.4× 90 0.5× 105 0.6× 106 1.6k
Jin‐Yong Jeong South Korea 24 281 0.7× 286 0.8× 121 0.4× 120 0.6× 77 0.4× 47 1.4k
John Merlino United States 27 326 0.8× 380 1.1× 187 0.7× 162 0.8× 27 0.1× 72 3.6k
Lei Tian China 17 181 0.4× 199 0.6× 128 0.5× 62 0.3× 82 0.4× 51 1.1k
Sophie Vimont France 16 815 1.9× 237 0.7× 85 0.3× 638 3.3× 72 0.4× 32 1.5k
Vassiliki Pitiriga Greece 21 498 1.2× 101 0.3× 62 0.2× 113 0.6× 51 0.3× 52 1.2k

Countries citing papers authored by Kiyoshi Moriyama

Since Specialization
Citations

This map shows the geographic impact of Kiyoshi Moriyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kiyoshi Moriyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kiyoshi Moriyama more than expected).

Fields of papers citing papers by Kiyoshi Moriyama

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kiyoshi Moriyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kiyoshi Moriyama. The network helps show where Kiyoshi Moriyama may publish in the future.

Co-authorship network of co-authors of Kiyoshi Moriyama

This figure shows the co-authorship network connecting the top 25 collaborators of Kiyoshi Moriyama. A scholar is included among the top collaborators of Kiyoshi Moriyama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kiyoshi Moriyama. Kiyoshi Moriyama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Sawa, Teiji, Kiyoshi Moriyama, & Mao Kinoshita. (2024). Current status of bacteriophage therapy for severe bacterial infections. Journal of Intensive Care. 12(1). 44–44. 35 indexed citations
3.
Inoue, Keita, Mao Kinoshita, Masaru Shimizu, et al.. (2023). Effect of a Novel Trivalent Vaccine Formulation against Acute Lung Injury Caused by Pseudomonas aeruginosa. Vaccines. 11(6). 1088–1088. 6 indexed citations
5.
Sawa, Teiji, et al.. (2020). Molecular epidemiology of clinically high‐risk Pseudomonas aeruginosa strains: Practical overview. Microbiology and Immunology. 64(5). 331–344. 19 indexed citations
6.
Higuchi, Satoshi, Yusuke Kabeya, Kenichi Matsushita, et al.. (2019). Perioperative Atrial Fibrillation in Noncardiac Surgeries for Malignancies and One-Year Recurrence. Canadian Journal of Cardiology. 35(11). 1449–1456. 20 indexed citations
7.
Naito, Yoshifumi, Mao Kinoshita, Masaru Shimizu, et al.. (2018). The protective effects of nasal PcrV‐CpG oligonucleotide vaccination against Pseudomonas aeruginosa pneumonia. Microbiology and Immunology. 62(12). 774–785. 24 indexed citations
8.
Naito, Yoshifumi, Masaru Shimizu, Mao Kinoshita, et al.. (2017). Efficacy comparison of adjuvants in PcrV vaccine against Pseudomonas aeruginosa pneumonia. Microbiology and Immunology. 61(2). 64–74. 23 indexed citations
9.
Ando, Tadao, et al.. (2016). Intrathecal Administration of Morphine Decreases Persistent Pain after Cesarean Section: A Prospective Observational Study. PLoS ONE. 11(5). e0155114–e0155114. 21 indexed citations
10.
Moriyama, Kiyoshi, et al.. (2014). Hypoxemia and oxygen saturation by pulse oximeter. Journal of the Japanese Society of Intensive Care Medicine. 21(2). 175–176.
11.
Moriyama, Kiyoshi, et al.. (2012). Scheduled perioperative switch from oral sildenafil to intravenous epoprostenol in a patient with Eisenmenger syndrome undergoing a sigmoidectomy. Journal of Clinical Anesthesia. 24(6). 487–489. 3 indexed citations
12.
Seki, Hiroyuki, Sadatomo Tasaka, Koichi Fukunaga, et al.. (2010). Effect of Toll-like receptor 4 inhibitor on LPS-induced lung injury. Inflammation Research. 59(10). 837–845. 39 indexed citations
13.
Suhara, Tomohiro, et al.. (2010). [Airway management in a patient with cavernous hemangioma of the hypopharynx and larynx].. PubMed. 59(5). 618–21.
14.
Moriyama, Kiyoshi, Jeanine P. Wiener‐Kronish, & Teiji Sawa. (2009). Protective effects of affinity‐purified antibody and truncated vaccines against Pseudomonas aeruginosa V‐antigen in neutropenic mice. Microbiology and Immunology. 53(11). 587–594. 29 indexed citations
15.
Kipnis, Éric, Kirk C. Hansen, Teiji Sawa, et al.. (2008). Proteomic Analysis of Undiluted Lung Epithelial Lining Fluid. CHEST Journal. 134(2). 338–345. 23 indexed citations
16.
Ishizaka, Akitoshi, Sadatomo Tasaka, Hidefumi Koh, et al.. (2006). Contribution of High-Mobility Group Box-1 to the Development of Ventilator-induced Lung Injury. American Journal of Respiratory and Critical Care Medicine. 174(4). 400–407. 125 indexed citations
17.
Moriyama, Kiyoshi, Akitoshi Ishizaka, Morio Nakamura, et al.. (2004). Enhancement of the endotoxin recognition pathway by ventilation with a large tidal volume in rabbits. American Journal of Physiology-Lung Cellular and Molecular Physiology. 286(6). L1114–L1121. 41 indexed citations
18.
Tamura, Miki, Leonard R. Allmond, Kiyoshi Moriyama, et al.. (2004). Pseudomonas aeruginosa causes acute lung injury via the catalytic activity of the patatin-like phospholipase domain of ExoU*. Critical Care Medicine. 32(11). 2293–2299. 57 indexed citations
19.
Allmond, Leonard R., Temitayo Ajayi, Kiyoshi Moriyama, Jeanine P. Wiener-Kronish, & Teiji Sawa. (2004). V-Antigen Genotype and Phenotype Analyses of Clinical Isolates of Pseudomonas aeruginosa. Journal of Clinical Microbiology. 42(8). 3857–3860. 9 indexed citations
20.
Chino, Mitsuo, et al.. (1991). The amount of heavy metals derived from domestic sources in Japan. Water Air & Soil Pollution. 57-58(1). 829–837. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026